Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
attrition rates in phase II can be harrowing. “Right now there are some companies where the probability that a drug that enters phase II will actually get to phase III is only about 25 percent,” Paul explains. “Said another way 75 percent of drugs that en
<At present, the improvement of clinical success rates is the most urgent requirement. Indicative of high clinical attrition is the fact that of the nearly 1,020 clinical trials currently underway, only one gene therapy product has reached the market. >
yumom Local time: 03:06 Works in field Native speaker of: Japanese PRO pts in category: 4
Thank you, yumon-san !
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs
(or are passionate about them). Participation is free and the site has a strict confidentiality policy.